Tinavi Medical Technologies Co.,Ltd. (SHA:688277)
China flag China · Delayed Price · Currency is CNY
23.81
-0.38 (-1.57%)
At close: Mar 6, 2026

SHA:688277 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
283.26172.59206.71145.48145.6
Other Revenue
-6.253.3310.7110.43
283.26178.84210.04156.19156.02
Revenue Growth (YoY)
58.38%-14.85%34.48%0.11%14.80%
Cost of Revenue
-54.1871.1154.0250.04
Gross Profit
283.26124.66138.92102.17105.98
Selling, General & Admin
-188.11217.47164.98140.57
Research & Development
-85.6134.5114.59101.61
Other Operating Expenses
444.082.48-3.84-0.3-1.27
Operating Expenses
444.08282.39350.52277.04246.84
Operating Income
-160.83-157.73-211.6-174.87-140.86
Interest Expense
--9.14-6.43-3.95-3.35
Interest & Investment Income
-41.3958.971.368.73
Currency Exchange Gain (Loss)
-1.160.723.15-0.9
Other Non Operating Income (Expenses)
-0.05-0.09-0.06-0.04-0.05
EBT Excluding Unusual Items
-160.87-124.42-158.39-174.36-136.43
Gain (Loss) on Sale of Investments
-0.050.090.10.63
Gain (Loss) on Sale of Assets
-5.39-0.03-0.05-0.17
Other Unusual Items
-19.447.6530.1531.32
Pretax Income
-160.87-99.55-150.69-144.16-104.65
Income Tax Expense
23.1621.5810.61-31.82-22
Earnings From Continuing Operations
-184.03-121.13-161.3-112.34-82.65
Minority Interest in Earnings
--4.911.752.72
Net Income
-184.03-121.13-156.39-110.58-79.93
Net Income to Common
-184.03-121.13-156.39-110.58-79.93
Shares Outstanding (Basic)
449449447425421
Shares Outstanding (Diluted)
449449447425421
Shares Change (YoY)
0.05%0.40%5.05%1.10%8.13%
EPS (Basic)
-0.41-0.27-0.35-0.26-0.19
EPS (Diluted)
-0.41-0.27-0.35-0.26-0.19
Free Cash Flow
--135.34-391.53-147.1-316.42
Free Cash Flow Per Share
--0.30-0.88-0.35-0.75
Gross Margin
100.00%69.70%66.14%65.42%67.93%
Operating Margin
-56.78%-88.20%-100.74%-111.96%-90.28%
Profit Margin
-64.97%-67.73%-74.46%-70.80%-51.23%
Free Cash Flow Margin
--75.68%-186.41%-94.18%-202.80%
EBITDA
-128.93-125.83-187.6-157.52-130.04
EBITDA Margin
-45.52%-70.36%-89.32%-100.85%-83.35%
D&A For EBITDA
31.931.92417.3510.82
EBIT
-160.83-157.73-211.6-174.87-140.86
EBIT Margin
-56.78%-88.20%-100.74%-111.96%-90.28%
Revenue as Reported
-178.84210.04156.19156.02
Advertising Expenses
-1.592.271.912.36
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.